Seasonal allergic or perennial rhinitis: treatment-related local adverse events include: headache, epistaxis, pharyngitis, nasal burning, nasal irritation and nasal ulceration, which are typically observed with use of a corticosteroid nasal spray. Epistaxis was generally self-limiting and mild in severity. In the pediatric population, the incidence of adverse effects e.g., headache, epistaxis, nasal irritation and sneezing.
Rarely, immediate hypersensitivity reactions (e.g., bronchospasm, dyspnea) may occur after intranasal administration of mometasone furoate monohydrate.
Very rarely, anaphylaxis and angioedema have been reported.
Disturbances of taste and smell have been reported very rarely.
Nasal polyposis: in patients treated for nasal polyposis, the overall incidence of adverse events similar to that observed for patients with allergic rhinitis.
Acute rhinosinusitis: in patients treated for mild to moderate acute rhinosinusitis, the overall incidence of adverse events similar to that observed for patients with allergic rhinitis.